Arnold I. Caplan

Case Western Reserve University — United States

Medicine · Health Sciences

122h-index77.6kcitations566works4.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Mesenchymal stem cell research(189), Osteoarthritis Treatment and Mechanisms(143), Tissue Engineering and Regenerative Medicine(78), Proteoglycans and glycosaminoglycans research(76), Bone Tissue Engineering Materials(51)

Publications566 total

Bone marrow mesenchymal cells 1
˜The œbiomedical & life sciences collection.·2025Open Access
Bone marrow mesenchymal cells 2
˜The œbiomedical & life sciences collection.·2025
MSCs: A New Approach
2025
Culture Expansion Alters Human Bone Marrow–Derived Mesenchymal Stem Cell Production of Osteoarthritis-Relevant Cytokines and Growth Factors
Arthroscopy The Journal of Arthroscopic and Related Surgery·2024· 1 cited
80 Harnessing milieu-sensitive mesenchymal stem cells for optimal microbicidal activity
Journal of Cystic Fibrosis·2024· 1 cited
Amino Acid Uptake Limitations during Human Mesenchymal Stem Cell-Based Chondrogenesis
Tissue Engineering Part A·2024Open Access
MSCs mediate long-term efficacy in a Crohn’s disease model by sustained anti-inflammatory macrophage programming via efferocytosis
npj Regenerative Medicine·2024· 27 citedOpen Access
35 Mesenchymal stem cell antimicrobial peptides resolve infection in cystic fibrosis
Journal of Cystic Fibrosis·2023Open Access
List of contributors
Elsevier eBooks·2023
Pericytes as a Source of MSCs
Elsevier eBooks·2023· 1 cited
The U.S. Food and Drug Administration, the mechanism of action, and other considerations for cell-based therapy candidates
Experimental Biology and Medicine·2023· 3 citedOpen Access
Mesenchymal stem cells ameliorate inflammation in an experimental model of Crohn’s disease via the mesentery
2023· 2 citedOpen Access
CSC Conference program from Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance
2023Open Access
Data from Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance
2023Open Access
Data from Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance
2023Open Access
CSC Conference program from Cancer Stem Cells: Targeting the Roots of Cancer, Seeds of Metastasis, and Sources of Therapy Resistance
2023Open Access
Human Mesenchymal Stem Cell (hMSC) Donor Potency Selection for the “First in Cystic Fibrosis” Phase I Clinical Trial (CEASE-CF)
Pharmaceuticals·2023· 12 citedOpen Access
A phase I study assessing the safety and tolerability of allogeneic mesenchymal stem cell infusion in adults with cystic fibrosis
Journal of Cystic Fibrosis·2022· 22 cited
Heparan Sulfate: A Regulator of White Adipocyte Differentiation and of Vascular/Adipocyte Interactions
Biomedicines·2022· 3 citedOpen Access
Efficacy and Safety of MSC Cell Therapies for Hospitalized Patients with COVID-19: A Systematic Review and Meta-Analysis
Stem Cells Translational Medicine·2022· 23 citedOpen Access
page 1 of 29Next →

Frequent Co-authors

Stephen E. Haynesworth(6), Victor M. Goldberg(5), James E. Dennis(4), Scott P. Bruder(3), Brian Johnstone(3), Jung U. Yoo(3), Shigeyuki Wakitani(3), Luis A. Solchaga(3), David J. Fink(3), Donald P. Lennon(3), Diego Correa(2), Randell G. Young(2), V M Goldberg(2), Lindolfo da Silva Meirelles(2), Stanton L. Gerson(2), Hillard M. Lazarus(2), Jizong Gao(2), David L. Butler(2), Jean F. Welter(2), Hajime Ohgushi(2)